Clinical Specialist
Anteris Technologies
Clinical Specialist
Anteris Technologies
Transcatheter heart valves for aortic stenosis
Anteris® Technologies is a global structural heart company dedicated to revolutionizing cardiac care. With offices in Minneapolis, MN, US; Geneva, Switzerland; and Brisbane and Perth, Australia, we have a growing and inclusive team.
Our mission is to forge new frontiers in cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Transcatheter Aortic Valve Replacement (TAVR) technologies were originally designed for older, high-risk patients. Today, younger, more active patients need a better solution that will not just open and close but restore healthy heart function. We seek to restore healthy blood flow patterns by creating the world’s first biomimetic TAVR valve, DurAVR® THV. This cutting-edge valve, incorporating our proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.
We are seeking an experienced TAVR Clinical Specialist to play an integral part in clinical trial support and execution, while also advancing clinical evidence and valve science. In this role, the Clinical Specialist will be responsible for TAVI clinical trial case support and procedural expertise, and they will play an active role in driving trial enrollment and identifying ongoing educational opportunities to heart team members and the referring community. This individual will work closely in collaboration with Clinical Affairs, Regulatory, R&D, Quality and Marketing to ensure optimal clinical outcomes and complete enrollment as aligned with corporate goals and strategy.
This role may be filled at varying levels, depending on the candidate's previous experience, and will report to the Sr. Director of Field Operations. This position will require 50-70% travel to support trial-related activities and will start in Q4 of 2026. Preference given to candidates in New England.
At Anteris® Technologies, you'll be part of a team dedicated to enhancing the quality of life for patients with aortic stenosis through groundbreaking medical devices. Join us in our mission to revolutionize structural heart solutions.
Primary Responsibilities:
Required Skills, Knowledge, Experience & Qualifications:
Preferred Skills, Knowledge, Experience & Qualifications:
Compensation
Target base salary range: $145,000 – $200,000, plus eligibility for an annual short-term incentive (STI) targeted at 15% of base salary and equity participation. Final compensation will be determined based on experience and alignment with role requirements. Unfortunately, we are unable to sponsor work visas (OPT, H1B, etc.) at this time.
What We Offer:
Health and Wellness Offerings:
Note: We may require proof of COVID-19 vaccination to comply with health institutions, state, local municipality, and/or travel regulations.
Anteris Technologies recruits, employs, trains, compensates, and promotes regardless of race, religion, color, national origin, sex, disability, age, veteran status, and other protected status as required by applicable law. We have a clear vision: to be a place of belonging for all humans by promoting diversity, multiculturism and inclusion, as a goal and reflection across the organization. Diversity is more than a commitment - it is part of our mission to deliver the best structural heart products on a global scale.
Transcatheter heart valves for aortic stenosis
Anteris Technologies designs and sells heart valve systems for structural heart diseases, with a focus on aortic stenosis. Its flagship DurAVR Transcatheter Heart Valve (TAVR) system is delivered via a minimally invasive catheter, replacing a diseased aortic valve without open-heart surgery. The valve uses ADAPT treated tissue and a 3D single-piece design to create a durable valve that resists calcification for over 10 years. This makes its products suitable for hospitals and patients seeking safer, quicker recovery compared to traditional surgery. The company differentiates itself with its proprietary anti-calcification ADAPT tissue and its unique one-piece 3D valve design, aiming to provide long-lasting valve durability in the growing transcatheter market. Its goal is to improve patient outcomes through durable, minimally invasive heart valve solutions and to expand its share in the global medical devices market for aortic stenosis.
Explore more opportunities at Anteris Technologies